Skip to content
StockMarketAgent
Healthcare / Medical DistributionUpdated 2026-05-10 22:07 UTC

ACH stock hub

Accendra Health, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

ACHis not in this month’s coverageGet our monthly research letter — no spam
Fair value midpoint
n/a
Fair value pending
Upside to midpoint
n/a
Based on latest report
Confidence
n/a
Data quality and model convergence
Market cap
273.6M
NYSE
Market data

Live price

Current market quote for this ticker.

Current price
ACH
In the news

Latest news · ACH

Recent company headlines from major financial publishers.

Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Loading
Fetching the latest headlines.
Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming
DateLoading
Window
EPS estimate
Revenue estimate
Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E5.4
P25 12.3P50 18.4P75 33.1
Trailing P/En/a
P25 14.9P50 23.2P75 38.5
ROE-163.8
P25 -105.6P50 -46.5P75 -3.1
ROIC9.1
P25 -63.1P50 -27.3P75 0.5
Benchmarks - 1M
S&P 500n/a
Nasdaq Compositen/a
Dow Jones Industrial Averagen/a
Russell 2000n/a
Indicator catalog

All ACH market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields
226
Groups with data
11
Currency
USD
Showing 226 of 226 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

23
MetricValue
Cik
0000075252
Company name
Accendra Health, Inc.
Country
United States
Country code
US
Cusip
690732102
Employees
6,500
Employees Change
-16,700%
Employees Change Percent
-71.98
Enterprise value
$2.2B
Exchange
NYSE
Financial currency
USD
First seen
2026-05-09
Industry
Medical Distribution
Isin
US6907321029
Last refreshed
2026-05-10
Market cap
$273.6M
Market cap category
Micro-Cap
Price
$3.58
Price currency
USD
Rev Per Employee
424,928x
Sector
Healthcare
Symbol
ACH
Website
https://www.accendrahealth.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

10
MetricValue
Earnings Yield
-402.21%
EV Sales Forward
0.82x
EV/EBIT
14.74x
EV/EBITDA
5.97x
EV/Sales
0.78x
FCF yield
-106.98%
Forward P/E
5.35x
P/S ratio
0.1x
PEG ratio
2.59x
PS Forward
0.1x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

20
MetricValue
EBIT Margin
5.29%
EBITDA Margin
13.06%
Gross margin
46.68%
Gross Profit
$1.3B
Gross Profit Growth
0.7%
Gross Profit Growth3 Y
-12.41%
Gross Profit Growth5 Y
0.13%
Net Income
$-1.1B
Net Income Growth Quarters
1%
Net Income Growth Years
0%
Pretax Margin
-3.69%
Profit Margin
-39.85%
Profit Per Employee
$-169,330
ROA
2.57
Roa5y
3.56
ROCE
9.72
ROE
-163.8
Roe5y
-36.01
ROIC
9.14
Roic5y
8.49

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

16
MetricValue
Cagr10y
-19.52%
Cagr15y
-12.37%
Cagr1y
-53.89%
Cagr20y
-6.72%
Cagr3y
-42.29%
Cagr5y
-36.37%
Div CAGR10
-35.48%
Div CAGR3
-77.3%
Div CAGR5
-60.35%
EPS Growth Quarters
1
EPS Growth Years
0
Revenue Growth
3.06x
Revenue Growth Quarters
5x
Revenue Growth Years
2x
Revenue Growth3 Y
-34.78x
Revenue Growth5 Y
-20.1x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

18
MetricValue
Asset Turnover
$0.78
Assets
$2.5B
Cash
$282M
Current Assets
$547.9M
Current Liabilities
$947.1M
Debt
$2.2B
Debt EBITDA
$4.87
Equity
$-461M
Interest Coverage
1.28
Liabilities
$2.9B
Long Term Assets
$1.9B
Long Term Liabilities
$2B
Net Cash
$-1.9B
Net Cash By Market Cap
$-688
Net Debt EBITDA
$5.22
Tangible Book Value
$-1.8B
Tangible Book Value Per Share
$-24.1
WACC
5.22

Liquidity

Current-asset coverage and working-capital efficiency metrics.

6
MetricValue
Current ratio
0.58
Inventory Turnover
20.74
Net Working Capital
$-387.9M
Quick ratio
0.4
Working Capital
$-399.2M
Working Capital Turnover
$-23.99

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

4
MetricValue
Buyback Yield
-0.2%
Dividend per share
$0
Dividend Yield
0%
Last Dividend
$0

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

39
MetricValue
10Y total return
-88.6%
1Y total return
-53.87%
200-day SMA
3.65
3Y total return
-80.78%
50-day SMA
2.8
50-day SMA vs 200-day SMA
50under200
5Y total return
-89.56%
All Time High
49.16
All Time High Change
-92.72%
All Time High Date
2021-06-09
All Time Low
1.84
All Time Low Change
94.57%
All Time Low Date
2026-01-06
ATR
0.25
Beta
1.7
Beta1y
3.4
Beta2y
1.21
Ch YTD
27.86
High
3.8
High52
9.55
High52 Date
2025-07-01
High52ch
-62.51%
Low
3.58
Low52
1.84
Low52 Date
2026-01-06
Low52ch
94.57%
Ma50ch
27.67%
Price vs 200-day SMA
-1.97%
RSI
59.16
RSI Monthly
35.67
RSI Weekly
53.29
Sharpe ratio
-0.53x
Sortino ratio
-0.63
Total Return
-0.2%
Tr YTD
27.86
Tr15y
-86.2%
Tr1m
40.95%
Tr1w
-4.28%
Tr3m
49.79%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

16
MetricValue
Analyst Count
2
Analyst Count Top
1
Analyst Price Target Top
$2.75
Analyst Ratings
Buy
Analyst Ratings Top
Hold
Earnings EPS Estimate
$-0.09
Earnings Revenue Estimate
641,495,216x
Earnings Revenue Estimate Growth
-75.63x
Operating Income
$146.2M
Operating Income Growth
-6.55
Operating Income Growth3 Y
-20.31
Operating Income Growth5 Y
-9.46
Operating margin
5.29
Price target
$3.38
Price Target Change
$-5.59
Price Target Change Top
$-23.18

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

11
MetricValue
Float
56,113,289%
Float Percent
73.41%
Net Borrowing
203,500,000
Shares Insiders
9.36%
Shares Institutions
75.78%
Shares Out
76,437,917
Shares Qo Q
-0.76%
Shares Yo Y
0.2%
Short Float
12.22%
Short Ratio
8.14
Short Shares
8.97

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

63
MetricValue
Adjusted FCF
$-305.6M
Average Volume
713,543.05x
Bv Per Share
-6.03
CAPEX
$-191M
Ch10y
-89.89
Ch15y
-89.4
Ch1m
40.95
Ch1w
-4.28
Ch1y
-53.87
Ch20y
-82.83
Ch3m
49.79
Ch3y
-80.78
Ch5y
-89.57
Ch6m
12.58
Change
-4.28%
Change From Open
-3.76
Close
3.74
Days Gap
-0.53
Depreciation Amortization
214,524,000
Dollar Volume
3,140,984.6
Earnings Date
2026-05-11
Earnings Time
bmo
EBIT
$146.2M
EBITDA
$360.7M
EPS
$-14.32
F Score
3
FCF
$-292.7M
FCF EV Yield
-13.58x
FCF Per Share
$-3.83
Financing CF
188,078,000
Fiscal Year End
December
Founded
1,882
Goodwill
1,228,140,000
Income Tax
$729,000
Investing CF
144,423,000
Is Primary Listing
1
Is Spac
No
Last Earnings Date
2026-02-19
Last Report Date
2025-12-31
Last Split Date
2010-04-01
Last Split Type
Forward
Ma150
2.98
Ma150ch
20.01%
Ma20
3.49
Ma20ch
2.73%
Net CF
232,607,000
Next Earnings Date
2026-05-11
Open
3.72
Optionable
Yes
Position In Range
0
Ppne
365,260,000
Price Date
2026-05-08
Price EBITDA
$0.76
Relative Volume
1.23x
Revenue
2,762,032,000x
SBC By Revenue
0.47x
Share Based Comp
12,873,000
Tax By Revenue
0.03x
Tr20y
-75.12%
Tr6m
12.58%
Us State
Virginia
Volume
877,370
Z Score
0.62
Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate
n/a
Named kill scenarios are reviewed before any bullish rating can stand.
Moat score
n/a
Business quality stays separate from stock attractiveness.
Forward P/E
n/a
Valuation uses the full report model stack, not a single multiple.
Next action
Research pending
Final action steps are kept in the recommendation tab.
Income

Does ACH pay a dividend?

Capital-return profile for this ticker.

Performance

ACH stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

1Y total return
-53.9%
S&P 500 1Y: n/a
3Y total return
-80.8%
S&P 500 3Y: n/a
5Y total return
-89.6%
S&P 500 5Y: n/a
10Y total return
-88.6%
S&P 500 10Y: n/a
Ownership

Who owns ACH?

Insider, institutional, and short-interest positioning.

Institutional ownership
+75.8%
Float: +73.4% of shares outstanding
Insider ownership
+9.4%
Stake held by company insiders. Higher generally signals alignment.
Short interest
+12.2%
8.1 days to cover
Y/Y dilution
+0.2%
Negative means the company is buying back shares.
Technical

ACH momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)
59.2
Neutral momentum band
Price vs 200-day MA
-2.0%
50/200-day relationship not available
Beta (5Y)
1.70
More volatile than the market
Sharpe ratio
-0.53
Risk-adjusted return — higher is better; >1.0 is solid.
Questions

About ACH

Hub-level FAQ points readers to the deeper analysis pages.

What is the current ACH stock rating?

Accendra Health, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full ACH analysis?

The full report lives at /stocks/ACH/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for ACH?

The latest report frames ACH around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the ACH page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.